1. Home
  2. Labeler Index
  3. Emergent Manufacturing Operations Baltimore Llc
  4. 71655-103
  5. NDC Package Code: 71655-103-01 Raxibacumab

NDC Package 71655-103-01 Raxibacumab

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71655-103-01
Package Description:
1 VIAL, SINGLE-USE in 1 CARTON / 34 mL in 1 VIAL, SINGLE-USE
Product Code:
71655-103
Proprietary Name:
Raxibacumab
Non-Proprietary Name:
Raxibacumab
Substance Name:
Raxibacumab
Usage Information:
None.
11-Digit NDC Billing Format:
71655010301
NDC to RxNorm Crosswalk:
  • RxCUI: 1366571 - raxibacumab 1700 MG in 34 ML Injection
  • RxCUI: 1366571 - 34 ML raxibacumab 50 MG/ML Injection
  • RxCUI: 1366571 - raxibacumab 1700 MG per 34 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Emergent Manufacturing Operations Baltimore Llc
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • RAXIBACUMAB 50 mg/mL
    • Pharmacologic Class(es):
  • Anthrax Protective Antigen-directed Antibody Interactions - [MoA] (Mechanism of Action)
  • Anthrax Protective Antigen-directed Antibody - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125349
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    12-14-2012
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71655-103-01?

    The NDC Packaged Code 71655-103-01 is assigned to a package of 1 vial, single-use in 1 carton / 34 ml in 1 vial, single-use of Raxibacumab, a human prescription drug labeled by Emergent Manufacturing Operations Baltimore Llc. The product's dosage form is injection and is administered via intravenous form.

    Is NDC 71655-103 included in the NDC Directory?

    Yes, Raxibacumab with product code 71655-103 is active and included in the NDC Directory. The product was first marketed by Emergent Manufacturing Operations Baltimore Llc on December 14, 2012 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 71655-103-01?

    The 11-digit format is 71655010301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271655-103-015-4-271655-0103-01